MBX logo

Microbix Biosystems Inc. Stock Price

TSX:MBX Community·CA$41.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

MBX Share Price Performance

CA$0.30
0.00 (0.00%)
CA$0.30
0.00 (0.00%)
Price CA$0.30

MBX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

2 Risks
1 Reward

Microbix Biosystems Inc. Key Details

CA$14.8m

Revenue

CA$8.5m

Cost of Revenue

CA$6.3m

Gross Profit

CA$12.0m

Other Expenses

-CA$5.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.042
42.49%
-38.62%
21.4%
View Full Analysis

About MBX

Founded
1988
Employees
n/a
CEO
Cameron Groome
WebsiteView website
www.microbix.com

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Recent MBX News & Updates

Recent updates

No updates